Your session is about to expire
← Back to Search
Nicotine Replacement
Nicotine Replacement for Non-Small Cell Lung Cancer
N/A
Waitlist Available
Led By Theodore Brasky, PhD
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Head and neck cancer patients planning to undergo surgical resection of their index cancer or exploratory biopsies (tonsil cancer)
Current smokers of combustible cigarettes who smoke >= 4 days/week
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights
Study Summary
This trial will test if e-cigarettes are an effective way to help people quit smoking before surgery, in order to reduce the risk of surgery-related complications.
Eligible Conditions
- Non-Small Cell Lung Cancer
- Head and Neck Squamous Cell Carcinoma
- Squamous Cell Carcinoma
- Lung Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
You have head and neck cancer and are going to have surgery to remove the main tumor or have a biopsy done (for tonsil cancer).
Select...
You smoke cigarettes at least four days a week.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
7 day point prevalence of tobacco use
Acceptance measured by participation rate
Adherence
+13 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (JUUL)Experimental Treatment3 Interventions
Beginning 1 month before surgery, patients receive a JUUL e-cigarette and a 1 month supply e-liquid pods. After completion of surgery, patients receive another 1 month supply of e-liquid pods.
Group II: Arm II (usual care)Active Control3 Interventions
Patients receive usual care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nicotine
FDA approved
Find a Location
Who is running the clinical trial?
Ohio State University Comprehensive Cancer CenterLead Sponsor
316 Previous Clinical Trials
289,646 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,607 Previous Clinical Trials
40,913,944 Total Patients Enrolled
Theodore Brasky, PhDPrincipal InvestigatorOhio State University Comprehensive Cancer Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You smoke cigarettes at least four days a week.You have a type of cancer called non-small cell lung cancer (NSCLC) or squamous cell carcinoma of the head and neck.You have cancers in your nose, throat, thyroid, or glands.You have difficulty hearing.You are using or planning to use medication to quit smoking.You are currently using supplemental oxygen at home because of your lung cancer.You have head and neck cancer and are going to have surgery to remove the main tumor or have a biopsy done (for tonsil cancer).Your tumors cannot be removed through surgery.You are currently using e-cigarettes.You have difficulty using electronic cigarettes due to problems with your hands or fingers.
Research Study Groups:
This trial has the following groups:- Group 1: Arm I (JUUL)
- Group 2: Arm II (usual care)
Awards:
This trial has 3 awards, including:- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any open sign-ups for this research project?
"The information found on clinicaltrials.gov indicates that this trial is not currently enrolling participants, even though it was posted on November 1st 2022 and last modified on August 19th of the same year. Nevertheless, there are 4727 other studies actively recruiting patients at this time."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger